Adele Hannigan serves as the Chief Business Officer at RoukenBio since November 2019, where leadership involves building cross-functional teams and contributing to new molecular biology and cell engineering tools' development. Previously, Adele held key roles at TC BioPharm from February 2015 to October 2019, including Director of Strategy and Business Development Manager, focusing on cell therapy and process development. Earlier experience includes a role as a Cancer Research Scientist at EnGeneIC Ltd and a Post-Doctoral Research Scientist at Cancer Research UK Scotland Institute. Adele holds multiple degrees, including a Master’s Degree in Chemistry with Industrial Experience from The University of Edinburgh and two Ph.D.s in Oncology and Cancer Biology from the University of Glasgow.
This person is not in the org chart
This person is not in any teams
This person is not in any offices